AKTX

Akari Therapeutics
AKTX

16 hedge funds and large institutions have $1.71M invested in Akari Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

7% less capital invested

Capital invested by funds: $1.84M → $1.71M (-$126K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$54.9K
2
+$36.8K
3
+$5.89K
4
UBS Group
UBS Group
Switzerland
+$4.16K
5
VF
Virtu Financial
New York
+$3K

Top Sellers

1
-$93.5K
2
-$21.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.26M
2
$133K
3
$76.9K
4
$54.9K
5
$54K
6
$36.8K
7
$22.9K
8
$22.8K
9
$22K
10
$17K
11
$5.14K
12
$4.16K
13
$3K
14
$2.99K
15
$510
16
$171